Lam Pharmaceutical Corp Sample Contracts

WARRANT
Lam Pharmaceutical Corp • March 1st, 2001 • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
Contract
Subscription Agreement • September 29th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware

Each subscriber for a Share at $0.003 Dollars per Share (the “Share”) of Easton Pharmaceuticals Inc. (Easton Pharmaceuticals) a Wyoming corporation (“the Company”), must complete and execute the Subscription Documents in accordance with the instructions set forth below. The completed documents should be sent to Easton Pharmaceuticals Inc., at 265 Rimrock Road, North York, Ontario, Canada, M3J 3C6.

EMPLOYMENT AGREEMENT
Employment Agreement • September 29th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Ontario

This Management and Employment Agreement, effective November 01, 2013, is entered into, by and between Easton Pharmaceuticals Inc. a Wyoming registered Corporation with offices residing in Toronto, Canada (“the Company” or “Easton”), and Carla Pepe (The “Employee”).

DISTRIBUTORSHIP AGREEMENT
Distributorship Agreement • October 13th, 2004 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York

This Agreement is made as of the 30th day of January, 2004, between LAM PHARMACEUTICAL CORPORATION, a corporation subsisting under the laws of Delaware, United States of America and having a business address at 800 Sheppard Avenue West, Commercial Unit 1, Toronto, Ontario, Canada M3H 6B4 (hereinafter “LAM”) and China National Pharmaceutical Foreign Trade Corporation (SINOPHARM), a corporation subsisting under the laws of the Peoples’ Republic of China, having a business address of Unit A No. 48 Xihai Nanyan, Xicheng District, Beijing, China 100035 (hereinafter “Distributor")

EMPLOYMENT AGREEMENT
Employment Agreement • March 25th, 2016 • Easton Pharmaceuticals Inc. • Pharmaceutical preparations • Ontario

This Management and Employment Agreement, effective November 01, 2013, is entered into, by and between Easton Pharmaceuticals Inc. a Wyoming registered Corporation with offices residing in Toronto, Canada (“the Company” or “Easton”), and Carla Pepe (The “Employee”).

January 5, 2005
Confidentiality Agreement • January 11th, 2005 • Lam Pharmaceutical Corp • Pharmaceutical preparations • New York

The purpose of this provisional sale and purchase letter agreement (the “Provisional Agreement”) is to outline the terms of a proposed acquisition (the “Proposed Acquisition”) by LAM Pharmaceutical Corporation (the “Acquiror”) of 51% of the outstanding shares of Hynature Investments Ltd. (“Hynature”), all of which are owned by Finest Enterprises Limited (“Seller”), on the terms and subject to the conditions to be set forth in a definitive stock purchase agreement to be executed by the parties. The proposed terms of the acquisition are as follows.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!